Radiohalogens for imaging and therapy

被引:191
作者
Adam, MJ
Wilbur, DS
机构
[1] TRIUMF, Vancouver, BC V6T 2A3, Canada
[2] Univ British Columbia, Dept Chem, Vancouver, BC, Canada
[3] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA
关键词
D O I
10.1039/b313872k
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Radiohalogens play a very important role in radiopharmaceuticals used for medical imaging ( now referred to as molecular imaging) and therapy applications. Development of new radiopharmaceuticals that have radiohalogens incorporated requires an understanding of parameters that are unique to chemistry involving these radionuclides. Those parameters include requirement for production and purification of the halogen radionuclides, as well as development of reaction conditions for use with high specific activity short-lived radionuclides. In this tutorial review, several radiohalogens, their radiolabeling chemistry and their application to medical imaging and therapy are discussed.
引用
收藏
页码:153 / 163
页数:11
相关论文
共 42 条
[1]   SYNTHESIS OF L-6-[I-123]IODO-M-TYROSINE A POTENTIAL SPECT BRAIN IMAGING AGENT [J].
ADAM, MJ ;
PONCE, YZ ;
BERRY, JM .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1990, 28 (09) :1065-1072
[2]   Radiohalogenated carbohydrates for use in PET and SPECT [J].
Adam, MJ .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2002, 45 (02) :167-180
[3]   EVALUATION OF THE MONOAMINE UPTAKE SITE LIGAND [I-123] METHYL 3-BETA-(4-IODOPHENYL)-TROPANE-2-BETA-CARBOXYLATE ([I-123)BETA-CIT) IN NONHUMAN-PRIMATES - PHARMACOKINETICS, BIODISTRIBUTION AND SPECT BRAIN IMAGING COREGISTERED WITH MRI [J].
BALDWIN, RM ;
ZEAPONCE, Y ;
ZOGHBI, SS ;
LAURELLE, M ;
ALTIKRITI, MS ;
SYBIRSKA, EH ;
MALISON, RT ;
NEUMEYER, JL ;
MILIUS, RA ;
WANG, SY ;
STABIN, M ;
SMITH, EO ;
CHARNEY, DS ;
HOFFER, PB ;
INNIS, RB .
NUCLEAR MEDICINE AND BIOLOGY, 1993, 20 (05) :597-606
[4]  
Berei K., 1995, CHEM HALIDES PSEUDOH, P787
[5]  
BEREI K, 1985, ASTATINE GMELIN HDB
[6]   Radiohalogen incorporation into organic systems [J].
Bolton, R .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2002, 45 (06) :485-528
[7]   Stabilisation of [131I]meta-iodobenzylguanidine at room temperature as organic extract in ethyl acetate/chloroform [J].
Chattopadhyay, S ;
Das, MK ;
Sarkar, BR ;
Prabhakar, G ;
Mehra, KS ;
Ramamoorthy, N .
APPLIED RADIATION AND ISOTOPES, 2001, 54 (02) :241-244
[8]   LABELING OF A SEROTONINERGIC LIGAND WITH F-18 - [F-18] SETOPERONE [J].
CROUZEL, C ;
VENET, M ;
IRIE, T ;
SANZ, G ;
BOULLAIS, C .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1988, 25 (04) :403-414
[9]  
DENARDO GL, 1995, ANTIBODY IMMUNOCONJ, V8, P1
[10]  
ElWetery AS, 1997, J LABELLED COMPD RAD, V39, P631, DOI 10.1002/(SICI)1099-1344(199708)39:8<631::AID-JLCR8>3.0.CO